Global Kidney Cancer Drugs Market Insights and Forecast to 2026

Global Kidney Cancer Drugs Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Kidney Cancer Drugs Product Introduction
1.2 Market Segments
1.3 Key Kidney Cancer Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Kidney Cancer Drugs Market Size Growth Rate by Type
1.4.2 Angiogenesis Inhibitors
1.4.3 mTOR Inhibitors
1.4.4 Monoclonal Antibodies
1.4.5 Cytokine Immunotherapy (IL-2)
1.5 Market by Application
1.5.1 Global Kidney Cancer Drugs Market Size Growth Rate by Application
1.5.2 Renal cell carcinoma (RCC)
1.5.3 Transitional cell carcinoma (TCC)
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Kidney Cancer Drugs Market Size, Estimates and Forecasts
2.1.1 Global Kidney Cancer Drugs Revenue 2015-2026
2.1.2 Global Kidney Cancer Drugs Sales 2015-2026
2.2 Global Kidney Cancer Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Kidney Cancer Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Kidney Cancer Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Kidney Cancer Drugs Competitor Landscape by Players
3.1 Kidney Cancer Drugs Sales by Manufacturers
3.1.1 Kidney Cancer Drugs Sales by Manufacturers (2015-2020)
3.1.2 Kidney Cancer Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Kidney Cancer Drugs Revenue by Manufacturers
3.2.1 Kidney Cancer Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Kidney Cancer Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Kidney Cancer Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Kidney Cancer Drugs Revenue in 2019
3.2.5 Global Kidney Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Kidney Cancer Drugs Price by Manufacturers
3.4 Kidney Cancer Drugs Manufacturing Base Distribution, Product Types
3.4.1 Kidney Cancer Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Kidney Cancer Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Kidney Cancer Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Kidney Cancer Drugs Market Size by Type (2015-2020)
4.1.1 Global Kidney Cancer Drugs Sales by Type (2015-2020)
4.1.2 Global Kidney Cancer Drugs Revenue by Type (2015-2020)
4.1.3 Kidney Cancer Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Kidney Cancer Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Kidney Cancer Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Kidney Cancer Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Kidney Cancer Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Kidney Cancer Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Kidney Cancer Drugs Market Size by Application (2015-2020)
5.1.1 Global Kidney Cancer Drugs Sales by Application (2015-2020)
5.1.2 Global Kidney Cancer Drugs Revenue by Application (2015-2020)
5.1.3 Kidney Cancer Drugs Price by Application (2015-2020)
5.2 Kidney Cancer Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Kidney Cancer Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Kidney Cancer Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Kidney Cancer Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Kidney Cancer Drugs by Country
6.1.1 North America Kidney Cancer Drugs Sales by Country
6.1.2 North America Kidney Cancer Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Kidney Cancer Drugs Market Facts & Figures by Type
6.3 North America Kidney Cancer Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Kidney Cancer Drugs by Country
7.1.1 Europe Kidney Cancer Drugs Sales by Country
7.1.2 Europe Kidney Cancer Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Kidney Cancer Drugs Market Facts & Figures by Type
7.3 Europe Kidney Cancer Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Kidney Cancer Drugs by Region
8.1.1 Asia Pacific Kidney Cancer Drugs Sales by Region
8.1.2 Asia Pacific Kidney Cancer Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Kidney Cancer Drugs Market Facts & Figures by Type
8.3 Asia Pacific Kidney Cancer Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Kidney Cancer Drugs by Country
9.1.1 Latin America Kidney Cancer Drugs Sales by Country
9.1.2 Latin America Kidney Cancer Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Kidney Cancer Drugs Market Facts & Figures by Type
9.3 Central & South America Kidney Cancer Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Kidney Cancer Drugs by Country
10.1.1 Middle East and Africa Kidney Cancer Drugs Sales by Country
10.1.2 Middle East and Africa Kidney Cancer Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Kidney Cancer Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Kidney Cancer Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Description and Business Overview
11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Kidney Cancer Drugs Products Offered
11.1.5 Bayer Related Developments
11.2 Roche
11.2.1 Roche Corporation Information
11.2.2 Roche Description and Business Overview
11.2.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Roche Kidney Cancer Drugs Products Offered
11.2.5 Roche Related Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Corporation Information
11.3.2 GlaxoSmithKline Description and Business Overview
11.3.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GlaxoSmithKline Kidney Cancer Drugs Products Offered
11.3.5 GlaxoSmithKline Related Developments
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Description and Business Overview
11.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Novartis Kidney Cancer Drugs Products Offered
11.4.5 Novartis Related Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Description and Business Overview
11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Kidney Cancer Drugs Products Offered
11.5.5 Pfizer Related Developments
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Corporation Information
11.6.2 Abbott Laboratories Description and Business Overview
11.6.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Abbott Laboratories Kidney Cancer Drugs Products Offered
11.6.5 Abbott Laboratories Related Developments
11.7 Active Biotech
11.7.1 Active Biotech Corporation Information
11.7.2 Active Biotech Description and Business Overview
11.7.3 Active Biotech Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Active Biotech Kidney Cancer Drugs Products Offered
11.7.5 Active Biotech Related Developments
11.8 Amgen
11.8.1 Amgen Corporation Information
11.8.2 Amgen Description and Business Overview
11.8.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Amgen Kidney Cancer Drugs Products Offered
11.8.5 Amgen Related Developments
11.9 Argos Therapeutics
11.9.1 Argos Therapeutics Corporation Information
11.9.2 Argos Therapeutics Description and Business Overview
11.9.3 Argos Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Argos Therapeutics Kidney Cancer Drugs Products Offered
11.9.5 Argos Therapeutics Related Developments
11.10 ArQule
11.10.1 ArQule Corporation Information
11.10.2 ArQule Description and Business Overview
11.10.3 ArQule Sales, Revenue and Gross Margin (2015-2020)
11.10.4 ArQule Kidney Cancer Drugs Products Offered
11.10.5 ArQule Related Developments
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Description and Business Overview
11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Kidney Cancer Drugs Products Offered
11.1.5 Bayer Related Developments
11.12 Bionomics
11.12.1 Bionomics Corporation Information
11.12.2 Bionomics Description and Business Overview
11.12.3 Bionomics Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Bionomics Products Offered
11.12.5 Bionomics Related Developments
11.13 Bristol-Myers Squibb
11.13.1 Bristol-Myers Squibb Corporation Information
11.13.2 Bristol-Myers Squibb Description and Business Overview
11.13.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Bristol-Myers Squibb Products Offered
11.13.5 Bristol-Myers Squibb Related Developments
11.14 Cerulean Pharma
11.14.1 Cerulean Pharma Corporation Information
11.14.2 Cerulean Pharma Description and Business Overview
11.14.3 Cerulean Pharma Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Cerulean Pharma Products Offered
11.14.5 Cerulean Pharma Related Developments
11.15 Exelixis
11.15.1 Exelixis Corporation Information
11.15.2 Exelixis Description and Business Overview
11.15.3 Exelixis Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Exelixis Products Offered
11.15.5 Exelixis Related Developments
11.16 Genentech
11.16.1 Genentech Corporation Information
11.16.2 Genentech Description and Business Overview
11.16.3 Genentech Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Genentech Products Offered
11.16.5 Genentech Related Developments
11.17 immatics biotechnologies
11.17.1 immatics biotechnologies Corporation Information
11.17.2 immatics biotechnologies Description and Business Overview
11.17.3 immatics biotechnologies Sales, Revenue and Gross Margin (2015-2020)
11.17.4 immatics biotechnologies Products Offered
11.17.5 immatics biotechnologies Related Developments
11.18 Immunicum
11.18.1 Immunicum Corporation Information
11.18.2 Immunicum Description and Business Overview
11.18.3 Immunicum Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Immunicum Products Offered
11.18.5 Immunicum Related Developments
11.19 Ono Pharmaceutical
11.19.1 Ono Pharmaceutical Corporation Information
11.19.2 Ono Pharmaceutical Description and Business Overview
11.19.3 Ono Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Ono Pharmaceutical Products Offered
11.19.5 Ono Pharmaceutical Related Developments
11.20 Onyx Therapeutics
11.20.1 Onyx Therapeutics Corporation Information
11.20.2 Onyx Therapeutics Description and Business Overview
11.20.3 Onyx Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Onyx Therapeutics Products Offered
11.20.5 Onyx Therapeutics Related Developments
11.21 Oxford BioMedica
11.21.1 Oxford BioMedica Corporation Information
11.21.2 Oxford BioMedica Description and Business Overview
11.21.3 Oxford BioMedica Sales, Revenue and Gross Margin (2015-2020)
11.21.4 Oxford BioMedica Products Offered
11.21.5 Oxford BioMedica Related Developments
11.22 Prometheus Laboratories
11.22.1 Prometheus Laboratories Corporation Information
11.22.2 Prometheus Laboratories Description and Business Overview
11.22.3 Prometheus Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.22.4 Prometheus Laboratories Products Offered
11.22.5 Prometheus Laboratories Related Developments
11.23 Seattle Genetics
11.23.1 Seattle Genetics Corporation Information
11.23.2 Seattle Genetics Description and Business Overview
11.23.3 Seattle Genetics Sales, Revenue and Gross Margin (2015-2020)
11.23.4 Seattle Genetics Products Offered
11.23.5 Seattle Genetics Related Developments
11.24 Taiwan Liposome
11.24.1 Taiwan Liposome Corporation Information
11.24.2 Taiwan Liposome Description and Business Overview
11.24.3 Taiwan Liposome Sales, Revenue and Gross Margin (2015-2020)
11.24.4 Taiwan Liposome Products Offered
11.24.5 Taiwan Liposome Related Developments
11.25 Tracon Pharmaceuticals
11.25.1 Tracon Pharmaceuticals Corporation Information
11.25.2 Tracon Pharmaceuticals Description and Business Overview
11.25.3 Tracon Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.25.4 Tracon Pharmaceuticals Products Offered
11.25.5 Tracon Pharmaceuticals Related Developments
11.26 Wilex
11.26.1 Wilex Corporation Information
11.26.2 Wilex Description and Business Overview
11.26.3 Wilex Sales, Revenue and Gross Margin (2015-2020)
11.26.4 Wilex Products Offered
11.26.5 Wilex Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Kidney Cancer Drugs Market Estimates and Projections by Region
12.1.1 Global Kidney Cancer Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Kidney Cancer Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Kidney Cancer Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Kidney Cancer Drugs Sales Forecast (2021-2026)
12.2.2 North America: Kidney Cancer Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Kidney Cancer Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Kidney Cancer Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Kidney Cancer Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Kidney Cancer Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Kidney Cancer Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Kidney Cancer Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Kidney Cancer Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Kidney Cancer Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Kidney Cancer Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Kidney Cancer Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Kidney Cancer Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Kidney Cancer Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Kidney Cancer Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Kidney Cancer Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Kidney Cancer Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Kidney Cancer Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Kidney Cancer Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Kidney Cancer Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Kidney Cancer Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Kidney Cancer Drugs Market Segments
Table 2. Ranking of Global Top Kidney Cancer Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Kidney Cancer Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Angiogenesis Inhibitors
Table 5. Major Manufacturers of mTOR Inhibitors
Table 6. Major Manufacturers of Monoclonal Antibodies
Table 7. Major Manufacturers of Cytokine Immunotherapy (IL-2)
Table 8. Global Kidney Cancer Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 9. Global Kidney Cancer Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 10. Global Kidney Cancer Drugs Sales by Regions 2015-2020 (K Units)
Table 11. Global Kidney Cancer Drugs Sales Market Share by Regions (2015-2020)
Table 12. Global Kidney Cancer Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Kidney Cancer Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 14. Global Kidney Cancer Drugs Sales Share by Manufacturers (2015-2020)
Table 15. Global Kidney Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Kidney Cancer Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney Cancer Drugs as of 2019)
Table 17. Kidney Cancer Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Kidney Cancer Drugs Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Kidney Cancer Drugs Price (2015-2020) (USD/Unit)
Table 20. Kidney Cancer Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Kidney Cancer Drugs Product Type
Table 22. Date of International Manufacturers Enter into Kidney Cancer Drugs Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Kidney Cancer Drugs Sales by Type (2015-2020) (K Units)
Table 25. Global Kidney Cancer Drugs Sales Share by Type (2015-2020)
Table 26. Global Kidney Cancer Drugs Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Kidney Cancer Drugs Revenue Share by Type (2015-2020)
Table 28. Kidney Cancer Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 29. Global Kidney Cancer Drugs Sales by Application (2015-2020) (K Units)
Table 30. Global Kidney Cancer Drugs Sales Share by Application (2015-2020)
Table 31. North America Kidney Cancer Drugs Sales by Country (2015-2020) (K Units)
Table 32. North America Kidney Cancer Drugs Sales Market Share by Country (2015-2020)
Table 33. North America Kidney Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Kidney Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 35. North America Kidney Cancer Drugs Sales by Type (2015-2020) (K Units)
Table 36. North America Kidney Cancer Drugs Sales Market Share by Type (2015-2020)
Table 37. North America Kidney Cancer Drugs Sales by Application (2015-2020) (K Units)
Table 38. North America Kidney Cancer Drugs Sales Market Share by Application (2015-2020)
Table 39. Europe Kidney Cancer Drugs Sales by Country (2015-2020) (K Units)
Table 40. Europe Kidney Cancer Drugs Sales Market Share by Country (2015-2020)
Table 41. Europe Kidney Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Kidney Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 43. Europe Kidney Cancer Drugs Sales by Type (2015-2020) (K Units)
Table 44. Europe Kidney Cancer Drugs Sales Market Share by Type (2015-2020)
Table 45. Europe Kidney Cancer Drugs Sales by Application (2015-2020) (K Units)
Table 46. Europe Kidney Cancer Drugs Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Kidney Cancer Drugs Sales by Region (2015-2020) (K Units)
Table 48. Asia Pacific Kidney Cancer Drugs Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Kidney Cancer Drugs Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Kidney Cancer Drugs Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Kidney Cancer Drugs Sales by Type (2015-2020) (K Units)
Table 52. Asia Pacific Kidney Cancer Drugs Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Kidney Cancer Drugs Sales by Application (2015-2020) (K Units)
Table 54. Asia Pacific Kidney Cancer Drugs Sales Market Share by Application (2015-2020)
Table 55. Latin America Kidney Cancer Drugs Sales by Country (2015-2020) (K Units)
Table 56. Latin America Kidney Cancer Drugs Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Kidney Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Kidney Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 59. Latin America Kidney Cancer Drugs Sales by Type (2015-2020) (K Units)
Table 60. Latin America Kidney Cancer Drugs Sales Market Share by Type (2015-2020)
Table 61. Latin America Kidney Cancer Drugs Sales by Application (2015-2020) (K Units)
Table 62. Latin America Kidney Cancer Drugs Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Kidney Cancer Drugs Sales by Country (2015-2020) (K Units)
Table 64. Middle East and Africa Kidney Cancer Drugs Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Kidney Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Kidney Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Kidney Cancer Drugs Sales by Type (2015-2020) (K Units)
Table 68. Middle East and Africa Kidney Cancer Drugs Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Kidney Cancer Drugs Sales by Application (2015-2020) (K Units)
Table 70. Middle East and Africa Kidney Cancer Drugs Sales Market Share by Application (2015-2020)
Table 71. Bayer Corporation Information
Table 72. Bayer Description and Major Businesses
Table 73. Bayer Kidney Cancer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 74. Bayer Product
Table 75. Bayer Recent Development
Table 76. Roche Corporation Information
Table 77. Roche Description and Major Businesses
Table 78. Roche Kidney Cancer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Roche Product
Table 80. Roche Recent Development
Table 81. GlaxoSmithKline Corporation Information
Table 82. GlaxoSmithKline Description and Major Businesses
Table 83. GlaxoSmithKline Kidney Cancer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. GlaxoSmithKline Product
Table 85. GlaxoSmithKline Recent Development
Table 86. Novartis Corporation Information
Table 87. Novartis Description and Major Businesses
Table 88. Novartis Kidney Cancer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Novartis Product
Table 90. Novartis Recent Development
Table 91. Pfizer Corporation Information
Table 92. Pfizer Description and Major Businesses
Table 93. Pfizer Kidney Cancer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Pfizer Product
Table 95. Pfizer Recent Development
Table 96. Abbott Laboratories Corporation Information
Table 97. Abbott Laboratories Description and Major Businesses
Table 98. Abbott Laboratories Kidney Cancer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Abbott Laboratories Product
Table 100. Abbott Laboratories Recent Development
Table 101. Active Biotech Corporation Information
Table 102. Active Biotech Description and Major Businesses
Table 103. Active Biotech Kidney Cancer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Active Biotech Product
Table 105. Active Biotech Recent Development
Table 106. Amgen Corporation Information
Table 107. Amgen Description and Major Businesses
Table 108. Amgen Kidney Cancer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Amgen Product
Table 110. Amgen Recent Development
Table 111. Argos Therapeutics Corporation Information
Table 112. Argos Therapeutics Description and Major Businesses
Table 113. Argos Therapeutics Kidney Cancer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. Argos Therapeutics Product
Table 115. Argos Therapeutics Recent Development
Table 116. ArQule Corporation Information
Table 117. ArQule Description and Major Businesses
Table 118. ArQule Kidney Cancer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 119. ArQule Product
Table 120. ArQule Recent Development
Table 121. AVEO Pharmaceuticals Corporation Information
Table 122. AVEO Pharmaceuticals Description and Major Businesses
Table 123. AVEO Pharmaceuticals Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 124. AVEO Pharmaceuticals Product
Table 125. AVEO Pharmaceuticals Recent Development
Table 126. Bionomics Corporation Information
Table 127. Bionomics Description and Major Businesses
Table 128. Bionomics Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 129. Bionomics Product
Table 130. Bionomics Recent Development
Table 131. Bristol-Myers Squibb Corporation Information
Table 132. Bristol-Myers Squibb Description and Major Businesses
Table 133. Bristol-Myers Squibb Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 134. Bristol-Myers Squibb Product
Table 135. Bristol-Myers Squibb Recent Development
Table 136. Cerulean Pharma Corporation Information
Table 137. Cerulean Pharma Description and Major Businesses
Table 138. Cerulean Pharma Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 139. Cerulean Pharma Product
Table 140. Cerulean Pharma Recent Development
Table 141. Exelixis Corporation Information
Table 142. Exelixis Description and Major Businesses
Table 143. Exelixis Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 144. Exelixis Product
Table 145. Exelixis Recent Development
Table 146. Genentech Corporation Information
Table 147. Genentech Description and Major Businesses
Table 148. Genentech Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 149. Genentech Product
Table 150. Genentech Recent Development
Table 151. immatics biotechnologies Corporation Information
Table 152. immatics biotechnologies Description and Major Businesses
Table 153. immatics biotechnologies Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 154. immatics biotechnologies Product
Table 155. immatics biotechnologies Recent Development
Table 156. Immunicum Corporation Information
Table 157. Immunicum Description and Major Businesses
Table 158. Immunicum Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 159. Immunicum Product
Table 160. Immunicum Recent Development
Table 161. Ono Pharmaceutical Corporation Information
Table 162. Ono Pharmaceutical Description and Major Businesses
Table 163. Ono Pharmaceutical Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 164. Ono Pharmaceutical Product
Table 165. Ono Pharmaceutical Recent Development
Table 166. Onyx Therapeutics Corporation Information
Table 167. Onyx Therapeutics Description and Major Businesses
Table 168. Onyx Therapeutics Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 169. Onyx Therapeutics Product
Table 170. Onyx Therapeutics Recent Development
Table 171. Oxford BioMedica Corporation Information
Table 172. Oxford BioMedica Description and Major Businesses
Table 173. Oxford BioMedica Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 174. Oxford BioMedica Product
Table 175. Oxford BioMedica Recent Development
Table 176. Prometheus Laboratories Corporation Information
Table 177. Prometheus Laboratories Description and Major Businesses
Table 178. Prometheus Laboratories Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 179. Prometheus Laboratories Product
Table 180. Prometheus Laboratories Recent Development
Table 181. Seattle Genetics Corporation Information
Table 182. Seattle Genetics Description and Major Businesses
Table 183. Seattle Genetics Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 184. Seattle Genetics Product
Table 185. Seattle Genetics Recent Development
Table 186. Taiwan Liposome Corporation Information
Table 187. Taiwan Liposome Description and Major Businesses
Table 188. Taiwan Liposome Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 189. Taiwan Liposome Product
Table 190. Taiwan Liposome Recent Development
Table 191. Tracon Pharmaceuticals Corporation Information
Table 192. Tracon Pharmaceuticals Description and Major Businesses
Table 193. Tracon Pharmaceuticals Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 194. Tracon Pharmaceuticals Product
Table 195. Tracon Pharmaceuticals Recent Development
Table 196. Wilex Corporation Information
Table 197. Wilex Description and Major Businesses
Table 198. Wilex Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 199. Wilex Product
Table 200. Wilex Recent Development
Table 201. Global Kidney Cancer Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 202. Global Kidney Cancer Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 203. Global Kidney Cancer Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 204. Global Kidney Cancer Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 205. North America: Kidney Cancer Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 206. North America: Kidney Cancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 207. Europe: Kidney Cancer Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 208. Europe: Kidney Cancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 209. Asia Pacific: Kidney Cancer Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 210. Asia Pacific: Kidney Cancer Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 211. Latin America: Kidney Cancer Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 212. Latin America: Kidney Cancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 213. Middle East and Africa: Kidney Cancer Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 214. Middle East and Africa: Kidney Cancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 215. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 216. Key Challenges
Table 217. Market Risks
Table 218. Main Points Interviewed from Key Kidney Cancer Drugs Players
Table 219. Kidney Cancer Drugs Customers List
Table 220. Kidney Cancer Drugs Distributors List
Table 221. Research Programs/Design for This Report
Table 222. Key Data Information from Secondary Sources
Table 223. Key Data Information from Primary Sources
List of Figures
Figure 1. Kidney Cancer Drugs Product Picture
Figure 2. Global Kidney Cancer Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Angiogenesis Inhibitors Product Picture
Figure 4. mTOR Inhibitors Product Picture
Figure 5. Monoclonal Antibodies Product Picture
Figure 6. Cytokine Immunotherapy (IL-2) Product Picture
Figure 7. Global Kidney Cancer Drugs Sales Market Share by Application in 2020 & 2026
Figure 8. Renal cell carcinoma (RCC)
Figure 9. Transitional cell carcinoma (TCC)
Figure 10. Kidney Cancer Drugs Report Years Considered
Figure 11. Global Kidney Cancer Drugs Market Size 2015-2026 (US$ Million)
Figure 12. Global Kidney Cancer Drugs Sales 2015-2026 (K Units)
Figure 13. Global Kidney Cancer Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Kidney Cancer Drugs Sales Market Share by Region (2015-2020)
Figure 15. Global Kidney Cancer Drugs Sales Market Share by Region in 2019
Figure 16. Global Kidney Cancer Drugs Revenue Market Share by Region (2015-2020)
Figure 17. Global Kidney Cancer Drugs Revenue Market Share by Region in 2019
Figure 18. Global Kidney Cancer Drugs Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Kidney Cancer Drugs Revenue in 2019
Figure 20. Kidney Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Kidne

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs